Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze MCHX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate MCHX investment potential.

What is MCHX stock price today?

Get real-time MCHX stock price, historical data, and price charts on Financhill. Track MCHX performance with our advanced analysis tools.

Is MCHX a good investment?

Evaluate MCHX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy MCHX stock?

To buy MCHX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of MCHX?

View detailed market capitalization data and company valuation metrics for MCHX on our comprehensive analysis page.

What is the P/E ratio of MCHX?

Use our fundamental analysis tools to view MCHX P/E ratio and compare valuation metrics with industry peers.

What are MCHX earnings?

View MCHX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Marchex, Inc. 10K Form

Buy

MCHX
Marchex, Inc.

Last Price:

$1.65

Seasonality Move:

2.14%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-14	10Q	MCHX/Marchex, Inc. Quarterly
2024-02-08	10Q	MCHX/Marchex, Inc. Quarterly
2024-01-16	10Q	MCHX/Marchex, Inc. Quarterly
2023-11-13	10Q	MCHX/Marchex, Inc. Quarterly
2023-08-04	10Q	MCHX/Marchex, Inc. Quarterly
2023-05-05	10Q	MCHX/Marchex, Inc. Quarterly

Receive MCHX News And Ratings

See the #1 stock for the next 7 days that we like better than MCHX

MCHX Financial Statistics

Sales & Book Value

Annual Sales:	$48.1M
Cash Flow:	$-92K
Price / Cash Flow:	0
Annual Sales:	$0.73
Price / Book:	2.27

Profitability

EPS (TTM):	-0.11090
Net Income (TTM):	$-4.8M
Gross Margin:	$30.3M
Return on Equity:	-14.89%
Return on Assets:	-11.44%

Marchex, Inc. Earnings Forecast

Key Marchex, Inc. Financial Ratios

The Gross Profit Margin over the past 23 years for MCHX is 63.06%.
The Selling, General & Administrative Expenses for MCHX have been equal to 46.51% of Gross Profit Margin.
The Research & Development expenses have been 26.78% of Revenue.
The Net Earning history of MCHX is -10.28% of Total Revenues.
Per Share Earnings over the last 23 years have been positive in 10 years.

Marchex, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Media
Sector:	Communication Services
Current Symbol:	MCHX
CUSIP:	56624R
Website:	marchex.com

Debt

Debt-to-Equity Ratio:	0.03
Current Ratio:	2.42
Quick Ratio:	2.21

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	165

MCHX Technical Analysis vs Fundamental Analysis

Buy

Marchex, Inc. (MCHX) is a Buy

Is Marchex, Inc. a Buy or a Sell?

Marchex, Inc. stock is rated a Buy

The current Marchex, Inc. [MCHX] share price is $1.65. The Score for MCHX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.